Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-012941
Filing Date
2025-03-17
Accepted
2025-03-17 11:03:52
Documents
64
Period of Report
2025-01-31

Document Format Files

Seq Description Document Type Size
1 10-Q csbr-20250131.htm   iXBRL 10-Q 870092
2 EX-31.1 csbrq3131202510-qex311.htm EX-31.1 10780
3 EX-31.2 csbrq3131202510-qex312.htm EX-31.2 10880
4 EX-32.1 csbrq3131202510-qex321.htm EX-32.1 7916
  Complete submission text file 0001628280-25-012941.txt   5051678

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20250131.xsd EX-101.SCH 35438
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT csbr-20250131_cal.xml EX-101.CAL 55207
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT csbr-20250131_def.xml EX-101.DEF 121698
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20250131_lab.xml EX-101.LAB 510805
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20250131_pre.xml EX-101.PRE 326620
67 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20250131_htm.xml XML 672845
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-11504 | Film No.: 25742991
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)